Clinical Trial Update: Effect of Imatinib Mesylate and the Pharmacokinetics of Acetaminophen/Paracetamol in Patients With Newly Diagnosed, Previously Untreated Chronic Myeloid Leukemia in Chronic Phase (CML-CP) [Phase 1]

View source ↗

Summary

Phase 1 study evaluating imatinib mesylate and the pharmacokinetics of acetaminophen in patients with newly diagnosed chronic myeloid leukemia in chronic phase;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Acetaminophen (Acetaminophen)
• Gleevec (Imatinib)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Chronic Myeloid Leukemia (CML) | Phase 1 | Status: COMPLETED